Developing a prediction model for selecting patients with sarcoma
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Kantonsspital Winterthur KSW · NCT04300257
This study is trying to create a model that helps doctors choose the best treatment options for people with sarcoma based on their individual characteristics and tumor types.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Sex | All |
| Sponsor | Kantonsspital Winterthur KSW (other) |
| Locations | 8 sites (Winterthur, Canton of Zurich and 7 other locations) |
| Trial ID | NCT04300257 on ClinicalTrials.gov |
What this trial studies
This project aims to analyze various aspects of sarcoma care, including diagnostics, treatment, and follow-up. Through interdisciplinary collaboration, the study will develop predictive and prognostic criteria to enhance treatment outcomes for patients with sarcoma. The analysis will focus on patient characteristics, tumor types, histology, management strategies, recurrence rates, and overall survival. The goal is to create a model that can guide future patient selection for different diagnostic and treatment procedures.
Who should consider this trial
Good fit: Ideal candidates include individuals of all ages with malignant, intermediate, or selected benign bone or soft tissue tumors.
Not a fit: Patients who have documented objections to the use of their personal health data may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with sarcoma.
How similar studies have performed: Other studies have shown success in developing predictive models for cancer treatment, indicating potential for this approach in sarcoma care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Malignant and intermediate and selected benign bone or soft tissue tumors, acc. to the WHO coding list of the SSN * Female and male subjects of all ages Exclusion Criteria: * Documented objection of subsequent use of personal health data
Where this trial is running
Winterthur, Canton of Zurich and 7 other locations
- Kantonsspital Winterthur — Winterthur, Canton of Zurich, Switzerland (RECRUITING)
- SwissSarcomaNetwork — Winterthur, Canton of Zurich, Switzerland (RECRUITING)
- Ente Ospedaliero Cantonale — Bellinzona, Canton Ticino, Switzerland (RECRUITING)
- Kantonsspital Graubünden — Chur, Kanton Graubünden, Switzerland (RECRUITING)
- Luzerner Kantonsspital — Lucerne, Switzerland (RECRUITING)
- Pathologie Institut Enge — Zurich, Switzerland (RECRUITING)
- Klinik Hirslanden — Zurich, Switzerland (RECRUITING)
- Stadtspital Zürich Triemli — Zurich, Switzerland (RECRUITING)
Study contacts
- Principal investigator: Bruno Fuchs, Prof — SwissSarcomaNetwork
- Study coordinator: Bruno Fuchs, Prof.
- Email: bruno.fuchs@ksw.ch
- Phone: +41 52 266 25 33
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Sarcoma, Sarcoma, Epithelioid, Sarcoma, Soft Tissue, Sarcoma, Spindle Cell, Sarcoma, Bone